Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Emergent BioSolutions potential leukemia treatment receives 'orphan drug' status from FDA
Emergent BioSolutions potential leukemia treatment receives 'orphan drug' status from FDA
Emergent BioSolutions potential leukemia treatment receives 'orphan drug' status from FDA
Submitted by
admin
on December 1, 2011 - 12:56pm
Source:
Yahoo/AP
News Tags:
FDA
orphan drugs
Emergent BioSolutions
leukemia
TRU-016
non-Hodgkin's lymphoma
chronic lymphocytic leukemia
Headline:
Emergent BioSolutions potential leukemia treatment receives 'orphan drug' status from FDA
Do Not Allow Advertisers to Use My Personal information
